Micro-ultrasound experience and clinically significant prostate cancer detection: a center-level analysis of the optimum randomized trial
Melis Guer, Alon Lazarovich, Ferdinand Luger, Hannes Cash, Sangeet Ghai, L. Felipe Urdaneta-Salegui, Christian P. Pavlovich, Joseph Brito, Neal D. Shore, Julian P. Struck, Martin Schostak, Niklas Harland, Moisés Rodriguez-Socarrás, Wayne G. Brisbane, Giovanni Lughezzani, Harry Toledano, Mohammed Salah Ouertani, Petr Macek, Christopher Fung, Wendy Tu, Andreas Gusenleitner, Karsten Günzel, Peter F. Incze, Arvin K. George, José G. Pereira, Robert Jansen, Joseph Renzulli II, Laurence Klotz, Adam Kin Prostate Cancer and Prostatic Diseases
· Springer Nature
· 2026-10-28
· DOI: 10.1038/s41391-026-01171-y
Abstract
Prostate Cancer and Prostatic Diseases, Published online: 28 October 2026; doi:10.1038/s41391-026-01171-y Micro-ultrasound experience and clinically significant prostate cancer detection: a center-level analysis of the optimum randomized trial
Melis Guer, Alon Lazarovich, Ferdinand Luger, Hannes Cash, Sangeet Ghai, L. Felipe Urdaneta-Salegui et al. Micro-ultrasound experience and clinically significant prostate cancer detection: a center-level analysis of the optimum randomized trial. // Prostate Cancer and Prostatic Diseases. – 2026. – DOI: 10.1038/s41391-026-01171-y. – URL: https://www.nature.com/articles/s41391-026-01171-y
Melis Guer, Alon Lazarovich, Ferdinand Luger, Hannes Cash, Sangeet Ghai, L. Felipe Urdaneta-Salegui, Christian P. Pavlovich, Joseph Brito, Neal D. Shore, Julian P. Struck, Martin Schostak, Niklas Harland, Moisés Rodriguez-Socarrás, Wayne G. Brisbane, Giovanni Lughezzani, Harry Toledano, Mohammed Salah Ouertani, Petr Macek, Christopher Fung, Wendy Tu, Andreas Gusenleitner, Karsten Günzel, Peter F. Incze, Arvin K. George, José G. Pereira, Robert Jansen, Joseph Renzulli II, Laurence Klotz, & Adam Kin (2026). Micro-ultrasound experience and clinically significant prostate cancer detection: a center-level analysis of the optimum randomized trial. Prostate Cancer and Prostatic Diseases. https://doi.org/10.1038/s41391-026-01171-y
Melis Guer, et al. “Micro-ultrasound experience and clinically significant prostate cancer detection: a center-level analysis of the optimum randomized trial.” Prostate Cancer and Prostatic Diseases, 2026. doi:10.1038/s41391-026-01171-y.
@article{Guer2026,
title = {Micro-ultrasound experience and clinically significant prostate cancer detection: a center-level analysis of the optimum randomized trial},
author = {Guer, Melis and Lazarovich, Alon and Luger, Ferdinand and Cash, Hannes and Ghai, Sangeet and Urdaneta-Salegui, L. Felipe and Pavlovich, Christian P. and Brito, Joseph and Shore, Neal D. and Struck, Julian P. and Schostak, Martin and Harland, Niklas and Rodriguez-Socarrás, Moisés and Brisbane, Wayne G. and Lughezzani, Giovanni and Toledano, Harry and Ouertani, Mohammed Salah and Macek, Petr and Fung, Christopher and Tu, Wendy and Gusenleitner, Andreas and Günzel, Karsten and Incze, Peter F. and George, Arvin K. and Pereira, José G. and Jansen, Robert and II, Joseph Renzulli and Klotz, Laurence and Kin, Adam},
journal = {Prostate Cancer and Prostatic Diseases},
year = {2026},
doi = {10.1038/s41391-026-01171-y},
url = {https://www.nature.com/articles/s41391-026-01171-y}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...